DNAVEC CORPORATION

Production and the like of the development of the gene remedy formulation which is based on vector technology, development of the gene vaccine and rearrangement protein. Types Ecommerce -B2B (Business-to-Business) Staff Mamoru Hasegawa, Ph D. Position Representative Employment 35 Set up: 2003 Capital: 1,079,150,000
Address
Kannondai 1-25-11, Tsukuba, Ibaraki, 305-0856 Japan, Japan, 305-0856
E-mail
Map

Google Advertise

Who's Online

We have 913 guests online